Samuel D. Wright
- Immunology top 0.05%
- Immune Response and Inflammation 45
- Immunology and Allergy top 0.05%
- Cell Adhesion Molecules Research 33
- Microbiology top 0.05%
- Cancer Research top 0.5%
- Hematology top 0.5%
-
- Lipoproteins and Cardiovascular Health 34
- Cholesterol and Lipid Metabolism 31
-
- Monoclonal and Polyclonal Antibodies Research 26
-
- Drug Transport and Resistance Mechanisms 25
-
- Peroxisome Proliferator-Activated Receptors 24
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Co-authors
- Peter S. TobiasRichard J. UlevitchRobert RamosJohn C. MathisonSamuel C. SilversteinEric HailmanTian‐Quan CaiP A Detmers
- Journals
- The Journal of Experimental Medicine (29 papers)Journal of Biological Chemistry (24 papers)The Journal of Immunology (15 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Samuel D. Wright
217 papers receiving 28.3k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Immunology 13.9k
- Immunology and Allergy 3.9k
- Microbiology 2.1k
- Cancer Research 2.5k
- Hematology 1.7k
Countries citing papers authored by Samuel D. Wright
This map shows the geographic impact of Samuel D. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D. Wright more than expected).
Fields of papers citing papers by Samuel D. Wright
This network shows the impact of papers produced by Samuel D. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D. Wright. The network helps show where Samuel D. Wright may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Samuel D. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 22 | |
| 5 | 2017 | 9 | |
| 6 | Abstract 15780: CSL112, A Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Patients With Stable Atherothrombotic Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study | 2013 | 3 |
| 7 | 2013 | 74 | |
| 8 | Abstract 11855: CSL112, a Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Healthy Subjects: A, Placebo-Controlled, Double-Blinded, Randomized Single Ascending Dose Study | 2012 | 6 |
| 9 | 2009 | 28 | |
| 10 | 2002 | 12 | |
| 11 | 2001 | 60 | |
| 12 | 2001 | 28 | |
| 13 | 2001 | 146 | |
| 14 | 2001 | 85 | |
| 15 | 2000 | 177 | |
| 16 | 2000 | 170 | |
| 17 | 1998 | 69 | |
| 18 | 1996 | 82 | |
| 19 | LPS-dependent interaction of Mac-2-binding protein with immobilized CD14. | 1995 | 19 |
| 20 | 1992 | 118 |
About Samuel D. Wright
Samuel D. Wright is a scholar working on Immunology and Allergy, Immunology and Endocrinology, Diabetes and Metabolism, having authored 219 papers that have together received 29.2k indexed citations. Recurring topics across this work include Immune Response and Inflammation (45 papers), Lipoproteins and Cardiovascular Health (34 papers), Cell Adhesion Molecules Research (33 papers), Cholesterol and Lipid Metabolism (31 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), Drug Transport and Resistance Mechanisms (25 papers), Peroxisome Proliferator-Activated Receptors (24 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers). The work is most often cited by research in Immunology (13.9k citations), Immunology and Allergy (3.9k citations) and Microbiology (2.1k citations). Samuel D. Wright has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Peter S. Tobias, Richard J. Ulevitch, Robert Ramos, John C. Mathison, Samuel C. Silverstein, Eric Hailman, Tian‐Quan Cai, P A Detmers, Terje Espevik and M T Jong. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Biological Chemistry, The Journal of Immunology, Bioorganic & Medicinal Chemistry Letters and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.